HIRA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.225800E-01
Normal-vs-Stage2
2.028000E-01
Normal-vs-Stage3
2.299600E-02
Normal-vs-Stage4
2.277000E-01
Stage1-vs-Stage2
5.347900E-02
Stage1-vs-Stage3
3.853600E-02
Stage1-vs-Stage4
3.016800E-01
Stage2-vs-Stage3
1.094200E-01
Stage2-vs-Stage4
8.562800E-01
Stage3-vs-Stage4
1.113570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.651000E-01
Normal-vs-AfricanAmerican
8.392800E-01
Normal-vs-Asian
2.042600E-01
Caucasian-vs-AfricanAmerican
4.241200E-01
Caucasian-vs-Asian
5.639600E-01
AfricanAmerican-vs-Asian
1.880010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.542800E-01
Normal-vs-Female
4.423200E-01
Male-vs-Female
5.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.115600E-01
Normal-vs-Age(41-60Yrs)
4.734400E-01
Normal-vs-Age(61-80Yrs)
4.641600E-01
Normal-vs-Age(81-100Yrs)
3.283500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.960800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.322000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.013700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.851400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.622300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.875220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.872100E-02
Normal-vs-Daily Drinker
1.251830E-01
Normal-vs-Weekly Drinker
5.028800E-01
Normal-vs-Occasional Drinker
8.383800E-01
Normal-vs-Social Drinker
2.805600E-01
Non Drinker-vs-Daily Drinker
9.173000E-01
Non Drinker-vs-Weekly Drinker
1.995840E-01
Non Drinker-vs-Occasional Drinker
5.258000E-02
Non Drinker-vs-Social Drinker
2.206600E-01
Daily Drinker-vs-Weekly Drinker
2.957400E-01
Daily Drinker-vs-Occasional Drinker
6.140200E-02
Daily Drinker-vs-Social Drinker
3.254800E-01
Weekly Drinker-vs-Occasional Drinker
4.885200E-01
Weekly Drinker-vs-Social Drinker
8.395600E-01
Occasional Drinker-vs-Social Drinker
3.296000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.331600E-01
Normal-vs-Grade 2
8.743800E-01
Normal-vs-Grade 3
8.437800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.990200E-01
Grade 1-vs-Grade 3
1.720790E-01
Grade 1-vs-Grade 4
9.331600E-01
Grade 2-vs-Grade 3
3.213400E-01
Grade 2-vs-Grade 4
8.743800E-01
Grade 3-vs-Grade 4
8.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.679190E-01
Normal-vs-NonDiabetic
5.300400E-01
Diabetic-vs-NonDiabetic
1.540570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.524570E-01
Normal-vs-NoPancreatitis
4.834000E-01
Pancreatitis-vs-NoPancreatitis
6.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.129000E-01
Normal-vs-N1
2.305600E-01
N0-vs-N1
3.310200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.731400E-01
Normal-vs-TP53-NonMutant
9.503800E-01
TP53-Mutant-vs-TP53-NonMutant
4.995800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
